For liver transplant recipients, universal prophylaxis and preemptive strategies (using ganciclovir or valganciclovir) are similarly effective for preventing cytomegalovirus (CMV) disease (CMD).
Your search for ganciclovir returned 20 results
Livtencity is an orally bioavailable anti-CMV compound that targets and inhibits the UL97 protein kinase and its natural substrates.
Maribavir is an orally bioavailable anti-CMV compound that targets and inhibits the UL97 protein kinase and its natural substrates.
The new approvals include Besremi, Fyarro, Livtencity, Voxzogo, and Vuity.
The discontinuation is not due to manufacturing, product quality, safety or efficacy concerns.
Previous literature has speculated on an association between migraine headache and HSV.
The Food and Drug Administration (FDA) has granted Fast Track designation to IMC-1 (Innovative Med Concepts) for the treatment of fibromyalgia.
A list of medications routinely prescribed in primary care practice that should be used cautiously or avoided in patients with chronic kidney disease (CKD) was compiled in a recently published study in the Annals of Pharmacotherapy.
Despite the availability of shingles immunization and treatment options, the incidence of postherpetic neuralgia is increasing.
This CME/CEU activity is designed to give clinicians a better understanding of the pharmacology, indications, contraindications, benefits/risk and clinical trials data of a broad spectrum of new agents and those that have been granted a new indication.